Association of diabetes mellitus and mild cognitive impairment in middle-aged men and women

Journal of Alzheimer's Disease

Volumn 42, Issue 4, 2014, Pages 1269-1277

  Winkler, Angela ^a   Dlugaj, Martha ^a   Weimar, Christian ^a   Jöckel, Karl Heinz ^a   Erbel, Raimund ^a   Dragano, Nico ^b   Moebus, Susanne ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Aging; gender; mild cognitive impairment; population based studies; type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; COGNITION; CONTROLLED STUDY; DEPRESSION; DIABETIC PATIENT; DISEASE ASSOCIATION; EDUCATIONAL STATUS; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROLOGIC EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PROBLEM SOLVING; VERBAL MEMORY; AGE; COHORT ANALYSIS; DIABETES MELLITUS, TYPE 2; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY; RISK FACTOR; SEX DIFFERENCE; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS; SEX FACTORS;

EID: 84907976488     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-140696     Document Type: Article

References (42)

1. International Diabetes Federation (2013) IDF Diabetes Atlas.
2. Cheng G, Huang C, Deng H, Wang H (2012) Diabetes as a risk factor for dementia and mild cognitive impairment: A meta-analysis of longitudinal studies. Intern Med J 42, 484-491.
3. Petersen RC (2011) Clinical practice. Mild cognitive impairment. N Engl J Med 364, 2227-2234.
4. Roberts RO, Knopman DS, Geda YE, Cha RH, Pankratz VS, Baertlein L, Boeve BF, Tangalos EG, Ivnik RJ, Mielke MM, Petersen RC (2014) Associationofdiabetes with amnestic and nonamnestic mild cognitive impairment. Alzheimers Dement 10, 18-26.
5. Luchsinger JA, Reitz C, Patel B, Tang MX, Manly JJ, Mayeux R (2007) Relation of diabetes to mild cognitive impairment. Arch Neurol 64, 570-575.
6. Schmermund A, Möhlenkamp S, Stang A, Gronemeyer D, Seibel R, Hirche H, Mann K, Siffert W, Lauterbach K, Siegrist J, Jöckel KH, Erbel R (2002) Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: Rationale and design of the Heinz Nixdorf RECALL Study. Risk Factors, Evaluation of Coronary Calcium and Lifestyle. Am Heart J 144, 212-218.
7. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. Washington, DC.
8. World Health Organization (2004) The selection and use of essential medicines. World Health Organ Tech Rep Ser 920, 1-127.
9. Oswald WD, Fleischmann UM (1994) N ürnberger-Alters-Inventar (NAI), Hogrefe Verlag für Psychologie, Göttingen.
10. Aschenbrenner S, Tucha O, Lange KW (2000) Regensburger Wortflüssigkeits-Test (RWT), Hogrefe Verlag für Psychologie, Göttingen.
11. Shulman KI (2000) Clock-drawing: Is it the ideal cognitive screening test? Int J Geriatr Psychiatry 15, 548-561.
12. Wege N, Dlugaj M, Siegrist J, Dragano N, Erbel R, Jöckel KH, Moebus S, Weimar C (2011) Population-based distribution and psychometric properties of a short cognitive performance measure in the population-based Heinz Nixdorf Recall Study. Neuroepidemiology 37, 13-20.
13. UNESCO (1997) International standard classification of education (ISCED).
14. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erk-injuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC (2004) Mild cognitive impairment-beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J Intern Med 256, 240-246.
15. Icks A, Albers B, Haastert B, Pechlivanis S, Bokhof B, Slo-miany U, Erbel R, Jöckel KH, Kruse J, Nowotny B, Herder C, Giani G, Moebus S (2013) Diabetes incidence does not differ between subjects with and without high depressive symptoms-5-year follow-up results of the Heinz Nixdorf Recall Study. Diabet Med 30, 65-69.
16. Icks A, Kruse J, Dragano N, Broecker-Preuss M, Slomiany U, Mann K, Jöckel KH, Erbel R, Giani G, Moebus S (2008) Are symptoms of depression more common in diabetes? Results from the Heinz Nixdorf Recall study. Diabet Med 25, 1330-1336.
17. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) The seventh report of the joint national committee onprevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA 289, 2560-2572.
18. Stang A, Moebus S, Möhlenkamp S, Dragano N, Schmer-mund A, Beck EM, Siegrist J, Erbel R, Jöckel KH, Heinz Nixdorf Recall Study Investigative G (2006) Algorithms for converting random-zero to automated oscillometric blood pressure values, and vice versa. Am J Epidemiol 164, 85-94.
19. Radloff LS (1977) The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1, 385-401.
20. Hautzinger M, Bailer M (1993) Allgemeine Depressions Skala. Beltz Test GmbH.
21. Gasecki D, Kwarciany M, Nyka W, Narkiewicz K (2013) Hypertension, brain damage and cognitive decline. Curr Hypertens Rep 15, 547-558.
22. Ganguli M, Fu B, Snitz BE, Unverzagt FW, Loewenstein DA, Hughes TF, Chang CC (2014) Vascular risk factors and cognitive decline in a population sample. Alzheimer Dis Assoc Disord 28, 9-15.
23. Xu W, Qiu C, Gatz M, Pedersen NL, Johansson B, Fratiglioni L (2009) Mid-and late-life diabetes in relation to the risk of dementia:Apopulation-based twin study. Diabetes 58, 71-77.
24. Schnaider Beeri M, Goldbourt U, Silverman JM, Noy S, Schmeidler J, Ravona-Springer R, Sverdlick A, Davidson M (2004) Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology 63, 1902-1907.
25. Zilkens RR, Davis WA, Spilsbury K, Semmens JB, Bruce DG (2013) Earlier age of dementia onset and shorter survival timesin dementia patients with diabetes. Am J Epidemiol 177, 1246-1254.
26. Barnes DE, Yaffe K (2011) The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 10, 819-828.
27. Freitag MH, Peila R, Masaki K, Petrovitch H, Ross GW, White LR, Launer LJ (2006) Midlife pulse pressure and incidence of dementia: The Honolulu-Asia Aging Study. Stroke 37, 33-37.
28. Gao Y, Huang C, Zhao K, Ma L, Qiu X, Zhang L, Xiu Y, Chen L, Lu W, Huang C, Tang Y, Xiao Q (2013) Depression as arisk factor for dementia and mild cognitive impairment: A meta-analysis oflongitudinal studies. Int J Geriatr Psychiatry 28, 441-449.
29. Roy T, Lloyd CE (2012) Epidemiology of depression and diabetes: A systematic review. J Affect Disord 142 (Suppl), S8-S21.
30. Abate KH (2013) Gender disparity in prevalence of depression among patient population: A systematic review. Ethiop J Health Sci 23, 283-288.
31. Ali S, Stone MA, Peters JL, Davies MJ, Khunti K (2006) The prevalence of co-morbid depression in adults with Type 2 diabetes: A systematic review and meta-analysis. Diabet Med 23, 1165-1173.
32. Roberts RO, Knopman DS, Mielke MM, Cha RH, Pankratz VS, Christianson TJ, Geda YE, Boeve BF, Ivnik RJ, Tan-galos EG, Rocca WA, Petersen RC (2014) Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal. Neurology 82, 317-325.
33. Peila R, Rodriguez BL, Launer LJ (2002) Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 51, 1256-1262.
34. Wixted JT, Squire LR (2010) The role of the human hippocampus in familiarity-based and recollection-based recognition memory. Behav Brain Res 215, 197-208.
35. Dore S, Kar S, Rowe W, Quirion R (1997) Distribution and levelsof [125I]IGF-I, [125I]IGF-II and [125I]insulin receptor binding sites inthe hippocampusofaged memory-unimpaired and-impaired rats. Neuroscience 80, 1033-1040.
36. Gasparini L, Xu H (2003) Potential roles of insulin and IGF-1 in Alzheimer's disease. Trends Neurosci 26, 404-406.
37. Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Guenette S (2003) Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 100, 4162-4167.
38. Schneider JA, Arvanitakis Z, Bang W, Bennett DA (2007) Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 69, 2197-2204.
39. Ahtiluoto S, Polvikoski T, Peltonen M, Solomon A, Tuomile-hto J, Winblad B, Sulkava R, Kivipelto M (2010) Diabetes, Alzheimer disease, and vascular dementia: A population-based neuropathologic study. Neurology 75, 1195-1202.
40. Vagelatos NT, Eslick GD (2013) Type 2 diabetes as a risk factor for Alzheimer's disease: The confounders, interactions, and neuropathology associated with this relationship. Epidemiol Rev 35, 152-160.
41. Legato MJ, Gelzer A, Goland R, Ebner SA, Rajan S, Villagra V, Kosowski M (2006) Gender-specific care of the patient with diabetes: Review and recommendations. Gender Med 3, 131-158.
42. Bruce DG, Davis WA, Casey GP, Starkstein SE, Clarnette RM, Foster JK, Almeida OP, Davis TM (2008) Predictors of cognitive impairment and dementia in older people with diabetes. Diabetologia 51, 241-248.